Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation
-
1
Clínica Universitaria de Navarra
info
-
2
Instituto de Investigación Sanitaria de Navarra
info
Instituto de Investigación Sanitaria de Navarra
Pamplona, España
-
3
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
info
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, España
ISSN: 1130-0108
Year of publication: 2018
Volume: 110
Issue: 11
Pages: 734 - 736
Type: Article
More publications in: Revista Española de Enfermedades Digestivas
Abstract
We present the case of a liver transplant (LT) recipient donor who developed graft versus host disease (GVHD).The main features were cutaneous rash, diarrhea and pancytopenia. Mesenchymal cells were administered as part of the treatment. This is the first case of a patient with GVHD after LT reported to date. Despite the treatment, there was no improvement in aplasia or gastrointestinal symptoms and the patient died due to a disseminated infection.
Bibliographic References
- 10.3748/wjg.14.974
- 10.1111/ctr.12627
- 10.1097/TP.0000000000001406
- 4 Pérez-Saborido B, Asensio-Díaz E, Barrera-Rebollo A et al. Graft versus host disease as a complication after liver transplantation: A rare but serious association. Rev Esp Enferm Dig. 2016 Jan;108(1):49-50.
- 10.1016/j.transproceed.2012.05.036
- 10.1097/TXD.0000000000000691
- 10.1016/j.bbmt.2014.06.015
- 10.1371/journal.pone.0136991